Goldaracena, J. P., Garcia, J. P., Becerra, J. I., Punset, M. C., Garrastatxu, I. M., Gaztelu, M. d. M., . . . Carricas, M. S. (2018). 4cps-009 efficacy, safety and economic impact of vedolizumab in ulcerative colitis and crohn’s disease. Eur J Hosp Pharm.
Dyfyniad Arddull ChicagoGoldaracena, J Preciado, et al. "4cps-009 Efficacy, Safety and Economic Impact of Vedolizumab in Ulcerative Colitis and Crohn’s Disease." Eur J Hosp Pharm 2018.
Dyfyniad MLAGoldaracena, J Preciado, et al. "4cps-009 Efficacy, Safety and Economic Impact of Vedolizumab in Ulcerative Colitis and Crohn’s Disease." Eur J Hosp Pharm 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.